TCL Archive Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer October 25, 2013
TCL Archive NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement June 26, 1987
TCL Archive Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms April 6, 2012